South Street Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-112,233
Closed -$10.9M 61
2020
Q2
$10.9M Sell
112,233
-667
-0.6% -$62.1K 2.92% 20
2020
Q1
$9.38M Sell
112,900
-1,051
-0.9% -$103K 3.09% 19
2019
Q4
$12.7M Buy
113,951
+2,231
+2% +$229K 3.28% 20
2019
Q3
$11.1M Buy
111,720
+1,580
+1% +$157K 3.23% 16
2019
Q2
$10.9M Buy
110,140
+105
+0.1% +$10K 3.25% 17
2019
Q1
$12.1M Sell
110,035
-2,105
-2% -$220K 3.68% 11
2018
Q4
$10.3M Sell
112,140
-30
-0% -$3.04K 3.64% 12
2018
Q3
$12.4K Sell
112,170
-600
-0.5% -$62.5K 1.93% 12
2018
Q2
$10.5M Buy
112,770
+2,650
+2% +$228K 3.19% 17
2018
Q1
$9.13K Buy
110,120
+1,980
+2% +$176K 0.91% 18
2017
Q4
$9.85M Sell
108,140
-1,455
-1% -$121K 2.98% 17
2017
Q3
$8.35K Buy
109,595
+1,250
+1% +$94.5K 1.62% 22
2017
Q2
$8.13M Buy
108,345
+6,490
+6% +$450K 2.66% 22
2017
Q1
$6.64K Buy
101,855
+28,461
+39% +$1.68M 0.92% 27
2016
Q4
$4.04M Buy
+73,394
New +$4.03M 1.43% 30

Other funds holding PRAH

South Street Advisors's PRAH Position: Q3 2020 in Review

South Street Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 112,233 shares — an estimated $10.9M sold.

South Street Advisors first reported a position in PRAH in Q4 2016 and held it in 15 quarters. The position peaked at $12.7M in Q4 2019. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

  • South Street Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • South Street Advisors sold 112,233 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $10.9M.
  • South Street Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 15 quarters.
  • South Street Advisors's PRA Health Sciences, Inc. position peaked at $12.7M in Q4 2019.
  • 281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on South Street Advisors's 13F filing for Q3 2020, filed 26 Oct 2020.